Legend Capital — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Indi Molecularindimolecular.cominJun 2017✓ verified
Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.
BiotechDeep TechMedical DevicesCulver City, US
James Heath(Director)Leroy Hood(Director)Andreas Jurgeit(Director)Heather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Darren Cai(Director)
PartnerFrank Hong· solo GP
Co-investorsM VenturesAsset Management Company
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.